It's an OK announcement. We know the effectiveness of the drug is dependent on the administration of CBD to the epidermis or dermis. This ann doesn't specifically state the effectiveness of the drug but rather how much CBD it can deliver relative to competitors (3x - 5x). Put two and two together, and you have a round-about way of displaying the effectiveness of the drug.....
It is NOT the phase 1b trial for psoriasis - I suspect that is due soon (end of Q1; i.e. by the end of March). Clearly a lot here to look forward to.
The 1 pip change I suspect is due to the recent buying action. This has been factored into the SP. However, I have consequently noticed the 12c sell bid has been significantly changed. Cappers be gone?
Let's see how today pans out ... with upcoming anns, may see some buying at these levels.
Ann: Permetrex Outperforms Other CBD Topical Products, page-27
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.020(6.06%) |
Mkt cap ! $636.1M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 35.5¢ | 32.5¢ | $3.263M | 9.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 16367 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 99971 | 1 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |